Ferroptosis-associated macrophages suggest a potential ACSL1-PGE2-stromal iron homeostasis-related axis in endometriosis
Lab / animal
public-domain-us
Abstract
BACKGROUND: Endometriosis (EMs) is characterized by chronic inflammation, recurrent bleeding, oxidative stress, and disrupted local iron homeostasis. Although macrophages are important components of the immune microenvironment in EMs, their ferroptosis-related heterogeneity and potential association with iron homeostasis remain unclear. This study investigated ferroptosis-associated macrophages (FAMs) and their potential involvement in immune-iron homeostasis coupling in EMs.
METHODS: Publicly available single-cell RNA sequencing data were used to characterize macrophage heterogeneity in eutopic endometrial samples from women with EMs and disease-free controls. Differential expression, functional enrichment, donor-level, pseudobulk, pseudotime ordering, and inferred cell-cell communication analyses, together with independent bulk RNA sequencing, were used to prioritize candidate regulators. In vitro experiments included ferroptosis-related phenotype induction, ACSL1 knockdown, PGE2 quantification, EP2 receptor blockade, and iron-loading and chelation assays.
RESULTS: FAMs were preferentially enriched in the EMs group and exhibited elevated ferroptosis-related transcriptional activity. Integrative transcriptomic and donor-level analyses supported the prioritization of acyl-CoA synthetase long-chain family member 1 (ACSL1) as a candidate metabolic regulator. Ferrostatin-1 treatment significantly attenuated erastin-induced lipid peroxidation and cellular injury. ACSL1 knockdown markedly attenuated ferroptosis-related alterations and PGE2 secretion in macrophages. In endometriotic stromal cells, PGE2 treatment downregulated FTH1 expression, upregulated SLC40A1 expression, and elevated extracellular Fe³⁺ levels; these changes were partially reversed by EP2 receptor blockade. Iron chelation treatment significantly attenuated FAC-induced lipid peroxidation and cellular injury in macrophages.
CONCLUSION: The findings support a proposed macrophage-stromal interaction axis linking ACSL1-PGE2-associated signaling, stromal iron homeostasis-related changes, and extracellular iron loading, with potential intervention points involving ACSL1, PGE2/EP2 signaling, and iron homeostasis.
My notes (saved in your browser only)
MeSH descriptors
Funding
- funders
- [{'doi': None, 'name': 'the 2025 Anhui Provincial Health Research Project', 'awards': ['Grant No. YL-2026-13']}, {'doi': None, 'name': 'he National Natural Science Foundation of China', 'awards': ['Grant No. 82201820']}, {'doi': None, 'name': 'the 2024 Young and Middle-aged Teacher Training Action Project of Anhui Province', 'awards': ['Project No. YQZD2024030']}, {'doi': None, 'name': 'Anhui Provincial Research Project', 'awards': ['Project No. 202427b10020092']}]
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (46)
- Changing prostaglandin E2 (PGE2) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE2 receptor EP2 and EP4 via crossref
- Curcumin modulates the function of SPP1+ macrophages via NF-κB signaling to alleviate endometriosis via crossref
- Economic Implications of Endometriosis: A Review via crossref
- Endometriosis: Etiology, pathobiology, and therapeutic prospects via crossref
- Endometriosis: from iron and macrophages to exosomes. Is the sky clearing? via crossref
- EP2 receptor antagonism reduces peripheral and central hyperalgesia in a preclinical mouse model of endometriosis via crossref
- Eutopic macrophages facilitate endometriosis progression via ferroptosis-mediated release of S100A9 via crossref
- Ferroptosis and oxidative stress in endometriosis: A systematic review of the literature via crossref
- Impact of endometriosis on women's health-related quality of life: A national prospective cohort study via crossref
- Macrophages in endometriosis: key roles and emerging therapeutic opportunities-a narrative review via crossref
- Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis via crossref
- Progressively Diminished Prostaglandin E2 Signaling in Concordance with Increasing Fibrosis in Ectopic Endometrium via crossref
- Single-cell analysis identifies distinct macrophage phenotypes associated with prodisease and proresolving functions in the endometriotic niche via crossref
- The role of fibrosis in endometriosis: a systematic review via crossref
- The role of iron in the pathogenesis of endometriosis: a systematic review via crossref
- Use of selective PGE2 receptor antagonists on human endometriotic stromal cells and peritoneal macrophages via crossref
- doi:10.1016/j.bcp.2022.115357 via crossref
- doi:10.1038/s41587-023-01767-y via crossref
- doi:10.1038/s41592-019-0619-0 via crossref
- doi:10.1093/nar/gkac935 via crossref
- doi:10.1093/nar/gkaa1113 via crossref
- doi:10.1093/nar/gkae909 via crossref
- doi:10.1038/nmeth.4402 via crossref
- doi:10.1038/s41467-021-21246-9 via crossref
- doi:10.1038/s41467-021-22471-y via crossref
- doi:10.1016/j.metabol.2025.156470 via crossref
- doi:10.1016/j.isci.2023.107145 via crossref
- doi:10.1016/j.jot.2025.04.016 via crossref
- doi:10.1038/s41467-024-48151-1 via crossref
- doi:10.1056/nejmra1810764 via crossref
- doi:10.1002/wsbm.1644 via crossref
- doi:10.1016/s0140-6736(21)00389-5 via crossref
- doi:10.1016/j.cell.2012.03.042 via crossref
- doi:10.1038/s41580-020-00324-8 via crossref
- doi:10.1038/s41422-020-00441-1 via crossref
- doi:10.1007/s10565-025-10010-0 via crossref
- doi:10.1038/nchembio.2239 via crossref
- doi:10.1038/nchembio.2238 via crossref
- doi:10.1016/j.molcel.2022.03.022 via crossref
- doi:10.1016/j.tem.2024.09.003 via crossref
- doi:10.1016/j.cell.2022.10.007 via crossref
- doi:10.1016/j.it.2024.06.006 via crossref
- doi:10.1172/jci.insight.132964 via crossref
- doi:10.1016/j.exphem.2021.08.011 via crossref
- doi:10.1038/s41392-020-00443-w via crossref
- doi:10.7150/thno.63396 via crossref
Source provenance
- crossref
- last seen: 2026-11-11T07:04:10.115598+00:00
- pubmed
- last seen: 2026-11-11T06:06:14.083101+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine